Cyclin D1 repression of peroxisome proliferator-activated receptor γ expression and transactivation

Molecular and Cellular Biology

Volumn 23, Issue 17, 2003, Pages 6159-6173

  Wang, Chenguang ^a   Pattabiraman, Nagarajan ^a   Zhou, Jian Nian ^b   Fu, Maofu ^a   Sakamaki, Toshiyuki ^a   Albanese, Chris ^a   Li, Zhiping ^a   Wu, Kongming ^a   Hulit, James ^b   Neumeister, Peter ^b   Novikoff, Phyllis M ^b   Brownlee, Michael ^b   Scherer, Philipp E ^b   Jones, Joan G ^b   Whitney, Kathleen D ^b   Donehower, Lawrence A ^c   Harris, Emily L ^d   Rohan, Thomas ^b   Johns, David C ^e   Pestell, Richard G ^a,f  

^a GEORGETOWN UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; HELIX LOOP HELIX PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; FATTY LIVER; FIBROBLAST; GENE ACTIVITY; GENE DELETION; GENE REPRESSION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RETROVIRUS; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSGENIC MOUSE;

3T3 CELLS; ANIMALS; BREAST; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CYCLIN D1; ECDYSTERONE; EPITHELIAL CELLS; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; REPRESSOR PROTEINS; THIAZOLES; THIAZOLIDINEDIONES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

ANIMALIA; MUS MUSCULUS; UNIDENTIFIED RETROVIRUS;

EID: 0042971664     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.17.6159-6173.2003     Document Type: Article

References (69)

1. Albanese, C., M. D'Amico, A. T. Reutens, M. Fu, G. Watanabe, R. J. Lee, R. N. Kitsis, B. Henglein, M. Avantaggiati, K. Somasundaram, B. Thimmapaya, and R. G. Pestell. 1999. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J. Biol. Chem. 274:34186-34195.
2. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
3. Albanese, C., A. Reutens, M. D'Amico, B. Boumediene, M. Fu, T. Link, R. Nicholson, R. A. Depinho, and R. G. Pestell. 2000. Sustained mammary gland directed ponasterone A-inducible expression in transgenic mice. FASEB J. 14:877-884.
4. Albanese, C., K. Wu, M. D'Amico, C. Jarrett, D. Joyce, J. Hughes, J. Hulit, T. Sakamaki, M. Fu, A. Ben-Ze'ev, J. F. Bromberg, C. Lamberti, U. Verma, R. B. Gaynor, S. W. Byers, and R. G. Pestell. 2003. IKKα regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol. Biol. Cell 14:585-599.
5. Alt, J. R., J. L Cleveland, M. Hannink, and J. A. Diehl. 2000. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:3102-3114.
6. Berg, A. H., T. Combatsiaris, X. L. Du, M. Brownlee, and P. E. Scherer. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7:947-953.
7. Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. H. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-242.
8. Brockman, J. A., R. A. Gupta, and R. N. Dubois. 1998. Activation of PPAR-gamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115:1049-1055.
9. Case, D. A., D. A. Pearlman, J. W. Caldwell, T. E. Cheatham III, J. Wang, W. S. Ross, C. L. Simmerling, T. A. Darden, K. M. Merz, R. V. Stanton, A. L. Cheng, J. J. Vincent, M. Crowley, V. Tsui, H. Gohlke, R. J. Radmer, Y. Duan, J. Pitera, I. Massova, G. L. Seibel, U. C. Singh, W. P. K., and K. P. A. 2002. AMBER 7. University of California, San Francisco, Calif.
10. BCR-ABL activity in transduced primary human hematopoietic cells controls lineage programming. Blood 99: 3197-3204.
11. Chawla, A., Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R. M. Evans. 2001. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7:48-52.
12. Combs, T. P., J. A. Wagner, J. Berger, T. Doebber, W. J. Wang, B. B. Zhang, M. Tanen, A. H. Berg, S. O'Rahilly, D. B. Savage, K. Chatterjee, S. Weiss, P. J. Larson, K. M. Gottesdiener, B. J. Gertz, M. J. Charron, P. E. Scherer, and D. E. Moller. 2002. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143:998-1007.
13. Davies, G. F., R. L. Khandelwahl, and W. J. Roesler. 1999. Troglitazone induces expression of PPARγ in liver. Mol. Cell. Biol. Res. Commun. 2;202-208.
14. Davies, G. F., P. J. McFie, R. L. Khandelwahl, and W. J. Roesler. 2002. Unique ability of troglitazone to upregulate peroxisome proliferator-activated receptor-g expression in hepatocytes. J. Pharmacol. Exp. Ther. 300: 72-77.
15. Elstner, E., C. Muller, K. Koshizuka, E. A. Williamson, D. Park, H. Asou, P. Shintaku, J. W. Said, D. Heber, and H. P. Koeffler. 1998. Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA 95:8806-8811.
16. Fajas, L., K. Schoonjans, L. Gelman, J. B. Kim, J. Najib, G. Martin, J. C. Fruchart, M. Briggs, B. M. Spiegelman, and J. Auwerx. 1999. Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol. Cell. Biol. 19:5495-5503.
17. Ganter, B., S.-L. Fu, and J. S. Lipsick. 1998. D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain. EMBO J. 17:255-268.
18. Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin. 1999. NF-κB controls cell growth and differentiation through the transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:5785-5799.
19. Hanahan, D., and R. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
20. Hoppe, U. C., E. Marban, and D. C. Johns. 1999. Adenovirus-mediated inducible expression in vivo by a hybrid ecdysone receptor. Mol. Ther. 1:159-164.
21. Inoue, K., and C. J. Sherr. 1998. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol. Cell. Biol. 18:1590-1600.
22. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
23. Karnovsky, M. J. 1965. A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J. Cell Biol. 27:137A-138A.
24. Kenny, F. S., R. Hui, E. A. Musgrove, J. M. Gee, R. W. Blamey, R. I. Nicholson, R. L. Sutherland, and J. F. Robertson. 1999. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clin. Cancer Res. 5:2069-2076.
25. Kroll, T. G., P. Sarraf, L. Pecciarini, C. J. Chen, E. Mueller, B. M. Spiegelman, and J. A. Fletcher. 2000. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma. Science 289:1357-1360.
26. Lee, R. J., C. Albanese, M. Fu, M. D'Amico, B. Lin, G. Watanabe, G. K. I. Haines, P. M. Siegel, M. C. Hung, Y. Yarden, J. M. Horowitz, W. J. Muller, and R. G. Pestell. 2000. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol. Cell. Biol. 20:672-683.
27. v-src signaling in breast cancer cells. J. Biol. Chem. 274:7341-7350.
28. Lefebvre, A. M., I. Chen, P. Desreumaux, J. Najib, J. C. Fruchart, K. Geboes, M. Briggs, R. Heyman, and J. Auwerx. 1998. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat. Med. 4:1053-1057.
29. Lillie, R. D. 1965. Histopathologic technic and practical histochemistry, 3rd ed. McGraw-Hill Book Co., Inc., New York, N.Y.
30. 1 checkpoint. Mol. Cell. Biol. 16:6917-6925.
31. Marx, N., F. Mach, A. Sauty, J. H. Leung, M. N. Sarafi, R. M. Ransohoff, P. Libby, J. Plutzky, and A. D. Luster. 2000. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J. Immunol. 164:6503-6508.
32. McMahon, C., T. Suthiphongchai, J. DiRenzo, and M. E. Ewen. 1999. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc. Natl. Acad. Sci. USA 96:5382-5387.
33. Mueller, E., P. Sarraf, P. Tontonoz, R. M. Evans, K. J. Martin, M. Zhang, C. Fletcher, S. Singer, and B. M. Spiegelman. 1998. Terminal differentiation of human breast cancer through PPARγ. Mol. Cell 1:465-470.
34. Neuman, E., M. H. Ladha, N. Lin, T. M. Upton, S. J. Miller, J. DiRenzo, R. G. Pestell, P. W. Hinds, S. F. Dowdy, M. Brown, and M. E. Ewen. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17:5338-5347.
35. Novikoff, A. B., P. M. Novikoff, C. Davis, and N. Quintana. 1972. Studies on Microperoxisomes. II. A cytochemical method for light and electron microscopy. J. Histochem. Cytochem. 2:1006-1022.
36. Novikoff, P. M., and A. B. Novikoff. 1972. Peroxisomes in absorptive cells of mammalian small intestine. J. Cell Biol. 53:532-560.
37. Novikoff, P. M., and A. Yam. 1978. Sites of lipoprotein particles in normal rat hepatocytes. J. Cell Biol. 76:1-11.
38. Peitsch, M. C. 1996. PROMOD and SWISS-MODEL: internet-based tools for automated comparative protein modeling. Biochem. Soc. Trans. 24:274-279.
39. Pestell, R. G., C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold. 1999. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocrine Rev. 20: 501-534.
40. Reutens, A. T., M. Fu, G. Watanabe, C. Albanese, M. J. McPhaul, S. P. Balk, O. A. Janne, J. J. Palvimo, and R. G. Pestell. 2001. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/ CBP-associated factor (P/CAF)-dependent manner. Mol. Endocrinol. 15: 797-811.
41. Rosen, E. D., C.-H. Hsu, X. Wang, S. Sakai, M. W. Freeman, F. J. Gonzalez, and B. M. Spiegelman. 2002. C/EBP induces adipogenesis through PPARγ: a unified pathway. Genes Dev. 16:22-26.
42. Rosen, E. D., P. Sarraf, A. E. Troy, G. Bradwin, K. Moore, D. S. Milstone, B. M. Spiegelman, and R. M. Mortensen. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4:611-617.
43. Rosen, E. D., and B. M. Spiegelman. 2001. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276:37731-37734.
44. Saez, E., P. Tontonoz, M. C. Nelson, J. G. Alvarez, U. T. Ming, S. M. Baird, V. A. Thomazy, and R. M. Evans. 1998. Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat. Med. 4:1058-1061.
45. Sarraf, P., E. Mueller, D. Jones, F. J. King, D. J. DeAngelo, J. B. Partridge, S. A. Holden, L. B. Chen, S. Singer, C. Fletcher, and B. M. Spiegelman. 1998. Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat. Med. 4:1046-1052.
46. Sarraf, P., E. Mueller, W. M. Smith, H. M. Wright, J. B. Kum, L. A. Aaltonen, A. de la Chapelle, B. M. Spiegelman, and C. Eng. 1999. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol. Cell 3:799-804.
47. Scherer, P. E., P. E. Bickel, M. Kotler, and H. F. Lodish. 1998. Cloning of cell-specific secreted and surface proteins by subtractive antibody screening. Nat. Biotechnol. 16:581-586.
48. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
49. 1-phase progression. Genes Dev. 13:1501-1512.
50. Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev. 1999. The cyclin D1 gene is a target of the β-catenin/ LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96:5522-5527.
51. Spiegelman, B. M. 1998. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514.
52. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156.
53. Wang, C., M. Fu, M. D'Amico, C. Albanese, J. N. Zhou, M. Brownlee, M. P. Lisanti, V. K. Chatterjee, M. A. Lazar, and R. G. Pestell. 2001. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol. Cell. Biol. 21:3057-3070.
54. Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
55. Wang, X. L., J. Oosterhof, and N. Duarte. 1999. Peroxisome proliferator-activated receptor gamma C161→T polymorphism and coronary artery disease. Cardiovasc. Res. 44:588-594.
56. Watanabe, G., C. Albanese, R. J. Lee, A. Reutens, G. Vairo, B. Henglein, and R. G. Pestell. 1998. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell. Biol. 18:3212-3222.
57. Watanabe, G., A. Howe, R. J. Lee, C. Albanese, I.-W. Shu, A. N. Karnezis, L. Zon, J. Kyriakis, K. Rundell, and R. G. Pestell. 1996. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93:12861-12866.
58. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
59. Westwick, J. K., Q. T. Lambert, G. J. Clark, M. Symons, L. Van Aelst, R. G. Pestell, and C. J. Der. 1997. Rac regulation of transformation, gene expression and actin organisation by multiple, PAK-independent pathways. Mol. Cell. Biol. 17:1324-1335.
60. 2-terminal kinase, p38/Mpk2, serum response factor, or c-Jun. J. Biol. Chem. 273:16739-16747.
61. Wu, Z., Y. Xie, N. L. Bucher, and S. R. Fanner. 1995. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev. 9:2350-2363.
62. Xu, H. E., M. H. Lambert, V. G. Montana, K. D. Plunket, L. B. Moore, J. L. Collins, J. A. Oplinger, S. A. Kliewer, R. T. Gampe, Jr., D. D. Mckee, J. T. Moore, and T. M. Willson. 2001. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 98:13919-13924.
63. Xu, H. E., T. B. Stanley, V. G. Montana, M. H. Lambert, B. G. Shearer, J. E. Cobb, D. D. Mckee, C. M. Galardi, K. D. Plunket, R. T. Nolte, D. J. Parks, J. T. Moore, S. A. Kliewer, T. M. Willson, and J. B. Stimmel. 2002. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR alpha. Nature 415:813-817.
64. Yu, B., M. E. Lane, R. G. Pestell, C. Albanese, and S. Wadler. 2000. Down-regulation of cyclin D1 alters cdk4 and cd2 specific phosphorylation of retinoblastoma protein. Mol. Cell. Biol. Res. Commun. 3:352-359.
65. Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021.
66. Yu, S., K. Matsusue, P. Kashireddy, W.-Q. Cao, V. Yeldandi, A. V. Yeldandi, M. S. Rao, F. J. Gonzalez, and J. K. Reddy. 2003. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor →1 (PPAR→1) overexpression. J. Biol. Chem. 278:498-505.
67. Zwijsen, R. M. L., R. S. Buckle, E. M. Hijmans, C. J. M. Loomans, and R. Bernards. 1998. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev. 12:3488-3498.
68. Zwijsen, R. M. L., R. Klompmaker, E. B. H. G. M. Wientjens, P. M. P. Kristel, B. van der Burg, and R. J. A. M. Michalides. 1996. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol. 16:2554-2560.
69. Zwijsen, R. M. L., E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards, and R. J. A. M. Michalides. 1997. CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415.